Abstract
Welcome to the first issue of 2012 of Cardiovascular & Hematological Agents in Medicinal Chemistry. I hope everyone has had a wonderful holiday season and I want to wish everyone a wonderful New Year. As you are aware, our journal aims to cover the latest and outstanding developments in medicinal chemistry, rational drug design for the discovery of novel cardiovascular and hematological agents and discusses such therapies in clinical practice. Each issue contains a series of timely in-depth reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in cardiovascular and hematological sciences. I feel that Cardiovascular & Hematological Agents in Medicinal Chemistry is an essential journal for every medicinal chemist, clinician and healthcare provider who wishes to be kept informed and up-to-date with the latest and most important developments in cardiovascular and hematological drug discovery and their clinical uses.
In the coming issues of the journal, we will discuss several important topics pertinent to medicinal chemists and clinicians in the cardiovascular and hematology field such as evidence for the use of adrenaline in the treatment of neonatal hypotension, use of selective Inhibitors of plasma kallikrein, potential cardiotoxic effect of clozapine, novel antiplatelets agents in cardiovascular medicine among others. Cardiovascular medicine and hematology are both very dynamic fields with rapid advances and we will continue to strive to keep you up to date on new advances and therapies.
I would also take this opportunity to invite our readers and experts to contribute hot topics and general articles in their respective fields to our journal. The journal is in its tenth successful year of publication, and is indexed by all major indexing media including Chemical Abstracts, EMBASE/Excerpta Medica, Index Medicus/MEDLINE, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Google, Google Scholar, Genamics JournalSeek, MediaFinder®-Standard Periodical Directory and Scopus and remains a valuable resource for chemists and clinicians.
18